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Inflammatory, anti-inflammatory and regulatory cytokines in relatively healthy 
lung tissue as an essential part of the local immune system
Zane Vitenberga, Mara Pilmane
Background. The innate and adaptive immune systems in lungs are maintained not only by immune cells but also by 
non-immune tissue structures, locally providing wide intercellular communication networks and regulating the local 
tissue immune response. 
Aims. The aim of this study was to determine the appearance and distribution of inflammatory, anti-inflammatory and 
regulatory cytokines in relatively healthy lung tissue samples. 
Material and Methods. We evaluated lung tissue specimens obtained from 49 patients aged 9–95 years in relatively 
healthy study subjects. Tissue samples were examined by hematoxylin and eosin staining. Interleukin-1 (IL-1), interleu-
kin-4 (IL-4), interleukin-6 (IL-6), interleukin-7 (IL-7), and interleukin-10 (IL-10) were detected by an immunohistochemistry 
(IMH) method. The number of positive structures was counted semiquantitatively by microscopy. Non-parametric tests 
were used to analyse the data.
Results. IL-1-positive cells were mostly found in the bronchial cartilage and alveolar epithelium. Immunoreactive 
lung macrophages were also found. The numbers of IL-4, IL-6, IL-7, and IL-10 containing cells were also found in the 
bronchial epithelium (in addition to those previously listed). The number of positive structures varied from occasional 
to moderate, but was graded higher in cartilage. Overall, fewer IL-1-positive cells and more IL-10-positive cells were 
found. Almost no positive structures for all examined cytokines were found in connective tissue and bronchial glands.
Conclusions. Relatively healthy lung tissue exhibits anti-inflammatory response patterns. The cytokine distribution 
and appearance suggest persistent stimulation of cytokine expression in lung tissue and indicate the presence of 
local regulatory and modulating patterns. The pronounced cytokine distribution in bronchial cartilage suggests the 
involvement of a compensatory local immune response in the supporting tissue. 
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INTRODUCTION
The complexity of the lung immune system extends 
beyond immunocompetent cells and their wide intercel-
lular signalling networks. Lung tissue immunity harbours 
necessary structures and forces for pathogen recogni-
tion, also maintaining various immune response types 
and tissue repair. In general, the lung innate and adap-
tive immune system in its steady state exhibits a gener-
ally anti-inflammatory environment1. Failure of immune 
response regulation might lead to a disrupted normal lung 
tissue architecture and structure due to minor and major 
structural changes2.
The barrier functions of epithelial tissue in the lung 
environment are essentially responsible for a major por-
tion of tissue homeostasis3. Epithelial tissue works as an 
outline barrier in the respiratory system3,4. Apart from 
true immune cells, epithelial tissue and its communication 
with other tissue structures design and shape signalling 
pathways to produce local immunity5. We can highlight 
the novel understanding of immune system, for which im-
munogenic properties have been described in other than 
immunocompetent cells. Interestingly, epithelial tissue 
is among the structures that possess immunogenicity6,7.
The airway epithelium works as a physical barrier 
in lungs to maintain effective mucociliary clearance8,9. 
Mucus covers the upper surface of the epithelium and 
actively serves as an environment capable of preventing 
airways from possible inhaled harm8,10.
Macrophages resident in non-immune tissue partici-
pate in tissue-specific homeostasis. Interestingly, tissue-
specific macrophages able to secrete extensive types of 
various biological molecules provide unique landscapes 
both in steady and active states, mirroring the ontogenetic 
and microenvironment background related to their role 
in shaping local homeostasis11,12. Moreover, tissue macro-
phages residing in certain organ-specific environments dis-
play high plasticity and may shape their cellular identity13. 
The interleukin-1 (IL-1) family has been found to have 
auto-inflammatory and autoimmune properties; however, 
IL-1 itself is a pro-inflammatory cytokine. IL-1 regulates 
the innate and adaptive immune system towards the ini-
tiation and amplification of the immune response into 
inflammation and regulates tissue damage. As a result 
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of the IL-1 presence in tissue, the recruitment of macro-
phages is a local immune response14. 
IL-4 is a key cytokine in the development of allergic 
inflammation and an important local factor participating 
in cell signalling due to allergen exposure15. IL-4 increases 
fibroblast proliferation and the secretion of extracellular 
matrix components leading to fibrosis16. IL-4 also highly 
promotes the pathogenesis of both allergy and asthma17.
IL-6 is a pro-inflammatory cytokine; however, the im-
portant anti-inflammatory and regenerative nature of IL-6 
has also been described18. Furthermore, the IL-6–medi-
ated profibrotic properties through the direct activation 
of fibroblasts and numerous indirect mechanisms have 
been reviewed16,19. 
IL-7 is also a cytokine with pleiotropic functions; 
however, IL-7 mostly functions as an immunoregulatory 
cytokine. Wide research has established IL-7 as the regu-
lator of lymphocyte overall development, maintenance 
and homeostasis20. IL-7 increases lymphoid cell lineage 
re-population and generation, serving as a lymphoid re-
generative factor21. Cytokine IL-7 is involved in the early 
development and further maintenance of T cells17,21. 
Immunity concepts have been reviewed with interest 
when considering the possible non-immune cell response 
to various inflammatory mediators as well as the produc-
tion of their own pro-inflammatory, regulatory and anti-
inflammatory mediators, not only by macrophages and in 
surface structures but also deeper in the tissue underlying 
the epithelium.
Thus, the aim of the present study was to perform a 
routine histological analysis and determine the appearance 
and relative distribution of interleukins (IL)-1, IL-4, IL-6, 
IL-7, and IL-10 in relatively normal lung tissue material.
MATERIALS AND METHODS
Patients
We evaluated lung tissue material obtained during a post 
mortem autopsy from forty-nine patients aged 9 to 95 years 
in relatively healthy study subjects. Among the diagnoses 
of the study subjects were heart disease (mostly sudden 
cardiac death) or death of the patients by either intentional 
self-harm (suicide) or unintentional major injury due to 
trauma. Tissues with surgically and histologically clear re-
section margins of suspected cancer patients were included 
in this study. Patients with severe respiratory conditions 
and failure, with any history of acute or severe chronic 
respiratory pathology, and treated with medications con-
flicting the possible results of this study, as well as tissue 
samples with pathological findings determined in routine 
histological analysis, were not included in this study. 
All authors hereby declare that all experiments were 
examined and approved by the appropriate ethics com-
mittee and were therefore performed in accordance with 
the ethical standards laid down in the 1964 Declaration 
of Helsinki. This study was approved by the Ethical 
Committee of Pauls Stradins Clinical University Hospital 
dated January 23, 2013.
Methodology
Soft tissue material pieces with an approximate size of 
1 cm3 were taken during the autopsy and further fixed in a 
mixture of 2% formaldehyde and 0.2% picric acid in 0.1 M 
phosphate buffer (pH 7.2). Afterwards, the tissue samples 
were rinsed in thyroid solution, containing 10% sucrose 
for 12 h. Continuing the rinsing, tissue specimens were 
embedded in paraffin. Six to seven micrometre (μm) thin 
tissue sections were cut to proceed with staining. Routine 
histological staining with hematoxylin and eosin was used 
for each case to obtain review photographs of each tis-
sue material. All the tissue specimens were examined by 
bright field microscopy. 
From sixty-nine tissue materials in total, we excluded 
twenty tissue specimens because pathological findings 
(e.g., massive immune cell infiltrations, bleeding, emphy-
sema) were observed by bright field microscopy, despite 
the clear medical history. 
Forty-nine tissue sections were prepared for the detec-
tion of cytokines IL-1α, IL-4, IL-6, IL-7, and IL-10 using 
the biotin-streptavidin immunohistochemistry (IMH) 
method22. The characteristics and parameters of the pri-
mary antibodies used in this study were as follows:
• IL-1α (code: sc-9983, mouse, work dilution 1:50, 
Santa Cruz Biotechnology),
• IL-4 (code: orb10908, rabbit, work dilution 1:100, 
Biorbyt),
• IL-6 (code: sc-130326, mouse, work dilution 1:50, 
Santa Cruz Biotechnology),
• IL-7 (code: orb48420, rabbit, work dilution 1:100, 
Biorbyt), 
• IL-10 (code: P22301, rabbit, work dilution 1:400, 
BioSite). 
The samples were examined under bright field mi-
croscopy using a Leica DC 300F camera microscope 
for conventional histological photographs. The acquired 
photographs were analysed using the picture visualization 
program Image Pro Plus.
We examined the appearance and distribution of cyto-
kine-containing structures, where the relative number of 
positive immunohistochemical structures in the epithelial 
tissue (precisely epithelial cells, both ciliated and secreto-
ry), connective tissue (fibroblasts), bronchial glands (both 
serous and mucous glandulocytes), bronchial cartilage 
(chondroblasts, chondrocytes), and alveolar epithelium, 
as well as cytokine-containing alveolar macrophages, were 
graded semi-quantitatively23,24. 
The following scale of the semi-quantitative method 
was used, counting the immunoreactive (positive) struc-
tures seen in the visual field: 0 – no positive structures 
(0%), 0/+ – occasional positive structures (12.5%), + – 
few positive structures (25%), +/++ – few to a moderate 
number of positive structures (37.5%), ++ – moderate 
number of positive structures (50%), ++/+++ – moderate 
number of to numerous positive structures (62.5%), +++ 
– numerous positive structures (75%), +++/++++ – numer-
ous to abundant positive structures (87.5%), ++++ – abun-
dance of positive structures (100%) observed in the visual 
field.
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Fig. 1. Representative microphotographs of relatively healthy lung tissue examined by routine histological staining with hematoxylin 
and eosin (a) and detection of cytokines IL-1α, IL-4, IL-6, IL-7, and IL-10 using the biotin-streptavidin immunohistochemistry 
(IMH) method (b – f). (a) An arrow marks dust-containing macrophages in the lung tissue of a 29-year-old male. Hematoxylin and 
eosin, X250. Scale bar, 16 μm. (b) Note the numerous IL-4–containing alveolar epithelial cells and alveolar macrophages (arrows) 
in the lung tissue of a 56-year-old male. IL-4 IMH, X200. Scale bar, 20 μm. (c) Note the moderate number of IL-6–containing 
bronchial epithelial cells in the squamous metaplastic epithelium in the lung tissue of a 45-year-old male. IL-6 IMH, X250. Scale 
bar, 16 μm. (d) Note the moderate IL-7–containing bronchial epithelial cells and few connective tissue fibroblasts indicated with an 
arrow (d) in the lung tissue of an 81-year-old female. IL-7 IMH, X400. Scale bar, 10 μm. (e) Note the moderate IL-10–containing 
bronchial epithelial cells in the lung tissue of a 27-year-old female. IL-10 IMH, X400. Scale bar, 10 μm. (f) Note the moderate IL-
10–containing hypertrophic hyaline cartilage cells in a large bronchus wall of a 30-year-old male. IL-10 IMH, X250. Scale bar, 16 μm.
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All the acquired data were ranking as ordinal values, 
where no positive structures (0) seen in visual field of 
bright field microscopy were ranked with the value of 0, 
occasional positive structures (0/+) were ranked with the 
value of 0.5, few positive structures (+) were ranked with 
the value 1.0, et cetera. The maximum grade of abundance 
of positive structures (++++) in the visual field was ranked 
with the value of 4.0. 
To perform the statistical analysis, we used nonpara-
metric statistical methods. 
• From the parameters analysed in descriptive statistics, 
the median (Mdn) value and interquartile range (IQR) 
were determined. 
• The Wilcoxon matched pairs Signed Rank Test was 
conducted to determine whether there was a differ-
ence in the number of positive structures of one exam-
ined cytokine (dependent variable) in two different tis-
sue types (independent variables, e.g., related groups), 
as well as to evaluate the positive ranks, negative ranks 
and ties. The data are medians unless otherwise stated.
• Spearman's rank-order correlation was run to deter-
mine the relationship between the number of cyto-
kine-containing structures in one type of tissue and 
in a different tissue, as well as with age. We evaluated 
the correlation coefficient as follows: The closer rs 
(Spearman’s rho) is to +1, the stronger the positive 
correlation. The closer rs is to -1, the stronger the nega-
tive correlation. The rs value of 0.00-0.30 is regarded 
as a negligible correlation; 0.30-0.50, as low; 0.50-0.70, 
as moderate; 0.70-0.90, as strong; and 0.90-1.00, as a 
very high (very strong) correlation25. 
The statistical analysis was performed using the 
statistical program SPSS Statistics, version 22.0 (IBM 
Company, Chicago, USA). In all the statistical analyses, 
P values < 0.05 were considered statistically significant.
RESULTS
Routine histology
Among the minor pathological findings, we evalu-
ated emphysematous lung tissue regions not larger than 
one visual field of bright field microscopy in two elderly 
patients. In the tissue materials of three patients, in-
creased smooth muscle cell proliferation was seen as a 
minor pathological finding in the wall of a conducting 
bronchus or bronchiole. Neoangiogenesis with few small-
calibre capillaries in the lung tissue parenchyma was seen 
in one case. Sclerotized blood vessels were found in the 
tissue materials of three elderly patients; however, these 
findings were rare in the whole tissue material. We found 
hemosiderin-containing macrophages and dust-containing 
macrophages (Fig. 1a) in three patients. 
Interestingly, we found goblet cell hyperplasia in the 
tissue material of one patient as a fragment of the lining 
epithelium with a size not exceeding one visual field at 
magnification X200. Goblet cell hyperplasia was seen as 
a unique lining epithelium covering the wall of a large-
calibre bronchus. Normal ciliated cells were partially re-
placed by an abundance of goblet cells. 
Immunohistochemistry
The number of IL-1–positive cells in the bronchial 
epithelium and connective tissue varied from no positive 
structures (0%) seen in the visual field to few-to-moder-
ate (+/++ or 37.5%) IL-1-containing structures (Fig. 1b). 
Almost no positive (0%) structures for IL-1 were detected 
in bronchial glands. Surprisingly, IL-1–containing struc-
tures in the bronchial cartilage were found more frequent-
ly. The number of IL-1–positive alveolar epithelial cells 
varied from no positive structures in the visual field to a 
moderate number (++ or 50%) observed. The count of 
IL-1 immunoreactive macrophages was also found to be 
variable, numbering from occasional (0/+ or 12.5%) to 
almost numerous (+++ or 75%) IL-1–containing macro-
phages. In summary, more IL-1 positive tissue structures 
were found in bronchial cartilage and alveolar epithelium, 
ranging from occasional (0/+ or 12.5%) to few (+ or 25%) 
immunoreactive structures seen in the visual field. No 
positive (0%) to only a few (+ or 25%) positive cells were 
found in the bronchial epithelium, connective tissue and 
bronchial glands.
IL-4–containing bronchial epithelial cells varied from 













Mdn Q1 Q3 Mdn Q1 Q3 Mdn Q1 Q3 Mdn Q1 Q3 Mdn Q1 Q3 Mdn Q1 Q3
IL-1 0.5 0 1.0 0.5 0 1.0 0 0 0 1.0 0.5 1.0 0.5 0.5 1.5 0.5 0.5 1.0
IL-4 1.5 0.75 1.5 0.5 0 0.5 0.5 0 1.0 0.5 0.5 1.0 1.0 0.5 1.75 1.5 0.5 2.0
IL-6 1.0 1.0 2.5 0.5 0 0.5 0 0 0 1.0 0.5 2.0 1.0 0.5 1.0 1.5 0.5 2.0
IL-7 1.25 1.0 1.5 0.5 0 1.0 0.5 0 0.5 2.0 1.5 2.5 1.0 0.75 2.0 0.75 0.5 2.0
IL-10 1.25 1.0 1.5 1.0 0.5 1.0 0.5 0 1.0 1.75 1.5 2.5 1.0 0.5 2.0 1.5 1.0 2.0
“0” – no positive (0) structures seen in the visual field, “0.5” – rare (0/+) positive structures seen in the visual field, “1.0” – few (+) positive struc-
tures seen in the visual field, “1.5” – few to a moderate (+/++) number of positive structures seen in the visual field, “2.0” – moderate (++) number 
of positive structures seen in the visual field, “2.5” – moderate to numerous (++/+++) positive structures seen in the visual field, “3.0” – numerous 
(+++) positive structures seen in the visual field, “IL-1” – interleukin-1, “IL-4” – interleukin-4, “IL-6” – interleukin-6, “IL-7” – interleukin-7, and 
“IL-10” – interleukin-10, “Mdn” – Median value, “Q1” – 25
th percentile value (1st Quartile), “Q3” – 75
th percentile value (3rd Quartile).
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occasional (0/+ or 12.5%) to numerous (+++ or 75%) IL-4 
positive cells. The number of IL-4–containing fibroblasts 
in the connective tissue varied from no positive (0%) 
structures to a moderate number (++ or 50%), except for 
two cases, where we evaluated numerous (+++ or 75%) 
IL-4–positive fibroblasts. Almost no positive (0%) to oc-
casional (0/+ or 12.5%) IL-4 positive glandulocytes and 
connective tissue fibroblasts were found in this study. 
Overall, the appearance of IL-4 positive structures in the 
bronchial cartilage and alveolar epithelium was graded 
from no positive (0%) structures to a moderate number 
(++ or 50%). The number of IL-4–containing alveolar 
macrophages varied from occasional (0/+ or 12.5%) to 
almost numerous (+++ or 75%). 
The appearance and distribution of IL-6 among the 
tissue groups of this study varied, ranging from occasional 
(0/+ or 12.5%) structures in the connective tissue and in 
the bronchial glands and mostly few (+ or 25%) struc-
tures in the alveolar epithelium. IL-6–containing struc-
tures were more prominent in the bronchial epithelium 
(Fig. 1c) and in the bronchial cartilage, mostly ranging 
from few to moderate (+/++ or 37.5%). In addition, few 
to moderate IL-6–containing macrophages were found in 
the majority of the examined tissue specimens.
Similar findings were seen in the analysis of the ap-
pearance and distribution of IL-7–positive structures 
(Fig. 1d), except for IL-7-containing alveolar epithelium, 
where few to moderate (+/++ or 37.5%) IL-7 positive epi-
thelial cells were found. Interestingly, from a moderate 
(++ or 50%) to numerous (+++ or 75%) IL-7 positive struc-
tures were found in bronchial cartilage, reaching overall 
the highest evaluation among all the examined cytokines.
The number of IL-10-containing structures in bron-
chial epithelium (Fig. 1e), in alveolar epithelium, as well 
as the number of alveolar macrophages varied from oc-
casional (0/+ or 12.5%) to numerous (+++ or 75%) struc-
tures seen in visual field, in average ranging from few 
to moderate (+/++ or 37.5%) number. Only occasional 
(0/+ or 12.5%) IL-10-containing glandulocytes were found 
in this study. Few (+ or 25%) fibroblasts positive for IL-
10 were found in majority of examined tissue specimens, 
Table 2. Summary of Spearman's rank-order correlation analysis to determine the strong relationship (0.70 > |rs| > 0.90) 
between the numbers of cytokine-containing structures in different tissues. The results are ordered in descending order by cor-
relation coefficient rs (Spearman’s rho). 
Tissue group (evaluated cytokine) n rs P
Alveolar epithelium (IL-1) Alveolar epithelium (IL-4) 24 0.823 <0.0005
Alveolar epithelium (IL-1) Bronchial glands (IL-6) 18 0.809 <0.0005
Alveolar epithelium (IL-4) Alveolar epithelium (IL-10) 24 0.804 <0.0005
Alveolar epithelium (IL-1) Alveolar epithelium (IL-10) 24 0.778 <0.0005
Bronchial epithelium (IL-10) Alveolar epithelium (IL-10) 19 0.769 <0.0005
Alveolar epithelium (IL-1) Alveolar epithelium (IL-7) 24 0.767 <0.0005
Alveolar epithelium (IL-6) Bronchial glands (IL-10) 18 0.763 <0.0005
Alveolar macrophages (IL-4) Bronchial glands (IL-10) 19 0.742 <0.0005
Alveolar epithelium (IL-1) Bronchial epithelium (IL-10) 19 0.715 0.001
Alveolar epithelium (IL-1) Bronchial glands (IL-10) 18 0.711 0.001
“n” – pairs analysed in Spearman’s rank-order correlation analysis, rs – correlation coefficient (Spearman’s rho), “P” – P values < 0.05 are consid-
ered statistically significant, “IL-1” – interleukin-1, “IL-4” – interleukin-4, “IL-6” – interleukin-6, “IL-7” – interleukin-7, and “IL-10” – interleukin-10.
Fig. 2. Comparison of IL-1α–containing structures in bronchial 
glands, bronchial cartilage and of the number of IL-1α–positive 
alveolar macrophages. “1” – z = -3.596, P < 0.0005, n = 18; “2” 
– z = -4.433, P < 0.0005, n = 38. 
where this result was seen as the most prominent among 
all cytokines evaluated in connective tissue. Moderate (++ 
or 50%) number of mostly IL-10-containing hypertrophic 
chondrocytes was found in bronchial cartilage (Fig. 1f).
Overall, the number of IL-4, IL-6, IL-7, IL-10 positive 
structures was considerably higher in the cartilage, alveo-
lar epithelium, and bronchial epithelium; furthermore, 
there was a more pronounced number of lung macro-
phages. No positive to few structures were found in the 
connective tissue and bronchial glands (Table 1).
Statistical data
We found a statistically significant (P < 0.05) lower 
number of IL-1 positive structures in bronchial glands 
(0), connective tissue and bronchial epithelium (0.5). A 
higher number of IL-1-containing structures were found 
in the bronchial cartilage; in addition, more alveolar mac-
rophages (1.0) were observed to containing IL-1. IL-1–
positive cells in the bronchial glands were fewer than in 
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the bronchial cartilage and were fewer compared with the 
number of alveolar macrophages (Fig. 2).
A statistically significant (P < 0.05) lower number 
of IL-4–containing structures were found in the con-
nective tissue, bronchial glands and bronchial cartilage 
(0.5); however, a higher number of IL-4 positive struc-
tures were found in the alveolar epithelium (1.0) and 
bronchial epithelium, and there was a higher number of 
IL-4–containing macrophages (1.5). IL-4–positive cells in 
the bronchial cartilage were fewer than in the bronchial 
epithelium and were fewer compared with the number of 
alveolar macrophages (Fig. 3).
Significantly (P < 0.05) fewer IL-6–positive structures 
were found in the bronchial glands (0) and connective 
tissue (0.5); however, more IL-6–positive structures were 
found in the bronchial epithelium, bronchial cartilage, 
Fig. 3. Comparison of IL-4–containing structures in bronchial 
cartilage, bronchial epithelium and of the number of IL-4 –con-
taining alveolar macrophages. “1” – z = -2.263, P = 0.024, n = 
20; “2” – z = -2.585, P = 0.01, n = 32.
Fig. 4. Comparison of IL-6–containing structures in bronchial 
glands, alveolar epithelium and of the number of IL-6–contain-
ing alveolar macrophages. “1” – z = -3.539, P < 0.0005, n = 18; 
“2” – z = -2.275, P < 0.023, n = 24; “3” – z = -3.487, P < 0.0005, 
n = 18.
Fig. 5. Comparison of IL-7–containing structures in bronchial 
epithelium, bronchial glands, bronchial cartilage and of the 
number of IL-7–containing alveolar macrophages. “1” – z = 
-4.181, P < 0.0005, n = 31; “2” – z = -2.762, P = 0.006, n = 20; 
“3” – z = -5.260, P < 0.0005, n = 39; “4” – z = -3.595, P < 0.0005, 
n = 30. 
Fig. 6. Comparison of IL-10–containing structures in bronchial 
epithelium, connective tissue, bronchial glands and bronchial 
cartilage. “1” – z = -5.335, P < 0.0005, n = 42; “2” – z = -4.191, 
P < 0.0005, n = 31; “3” – z = -5.277, P < 0.0005, n = 38; “4” – z 
= -4.081, P < 0.0005, n = 37.
and alveolar epithelium (1.0), as well as IL-6 containing 
alveolar macrophages (1.5). IL-6–positive cells in bron-
chial glands were fewer than in the alveolar epithelium 
and were fewer compared with the number of alveolar 
macrophages (Fig. 4).
A statistically significant (P < 0.05) lower number of 
IL-7–containing structures was found in the connective 
tissue, bronchial glands (0.5) and alveolar epithelium 
(1.0). A higher number of IL-7-containing structures were 
found in the bronchial epithelium (1.5) and in the bron-
chial cartilage (2.0), as well as a higher number of IL-7 
positive alveolar macrophages (1.5). IL-7–positive cells in 
the bronchial glands were fewer than in the bronchial epi-
thelium or bronchial cartilage and were fewer compared 
with the number of alveolar macrophages (Fig. 5).
Similarly, regarding the IL-7 distribution among the 
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examined tissues, a statistically significant (P < 0.05) 
lower number of IL-10–containing structures were found 
in the bronchial glands (0.5), connective tissue and al-
veolar epithelium (1.0). Furthermore, a higher number of 
IL-10 –containing structures were found in the bronchial 
epithelium (1.5) and bronchial cartilage (2.0), as well as 
a higher number of IL-7–positive alveolar macrophages 
(1.5). IL-10–positive cells in the bronchial glands and 
connective tissue were fewer than those in the bronchial 
epithelium and bronchial cartilage (Fig. 6).
A statistically significant (P < 0.05) positive correla-
tion with a strong relationship was found between the 
number of positive structures for mostly IL-1 and IL-10 
in the alveolar epithelium, as well as between the number 
of positive structures for IL-10 in bronchial epithelium 
and bronchial glands with positive structures for IL-4, 
IL-6 and IL-7. Interestingly, there was a strong, positive 
correlation between positive structures for IL-1 and IL-10 
in the alveolar epithelium (rs = 0.778, P < 0.001), alveo-
lar epithelium and bronchial epithelium (rs = 0.715, P = 
0.001), as well as alveolar epithelium and bronchial glands 
(rs = 0.711, P = 0.001), respectively (Table 2).
No statistically significant (P < 0.05) positive or nega-
tive correlations were determined between the number of 
positive structures in any tissue groups examined in this 
study and age.
DISCUSSION
Our study reveals a more pronounced number of IL-1–
containing structures in bronchial cartilage, as well as a 
higher number of IL-1–containing alveolar macrophages; 
however, fewer IL-1–positive structures were found in the 
bronchial epithelium, connective tissue and in alveolar 
epithelium. We also measured a strong correlation of ex-
clusively IL-1–containing alveolar epithelium dependent 
on other tissue groups containing predominantly IL-10, 
as well as IL-4, IL-6, and IL-7. Although we may speculate 
about the substantiation of IL-1 regulating all other cyto-
kines, conversely, the release of IL-1 is also regulated by 
other pro-inflammatory, regulating and anti-inflammatory 
cytokines; therefore, the causality of one cytokine affect-
ing another cytokine must be estimated in the context 
of multiple factors. In summary, epithelial cells are both 
activated by and further release the following cytokines: 
IL-1α, IL-4, IL-6 and IL-103,5-7,26. As the first exposed sur-
face, the airway epithelium actively regulates local immu-
nity. Due to antigen exposure, activated epithelial cells 
might recruit locally inhabiting immunocompetent cells. 
Epithelial cells use autocrine and paracrine signalling 
pathways to provide intercellular and intracellular com-
munication3, 4. In summary, epithelial tissue serves as a 
first-line defence system in the innate immune system due 
to the continuous exposure to airborne antigens, sensing 
potential danger and harm, while initiating, regulating and 
suppressing the adaptive immunity3. Pro-inflammatory 
cytokines (IL-1, IL-6) and chemokines produced by 
epithelial cells recruit and activate immune cells in the 
submucosa5. Importantly, specifically IL-1α even boosts 
the epithelial cell participation in the immune response 
through the autocrine stimulation8. However, to suppress 
the immune responses caused by the release of IL-1, the 
epithelium might release anti-inflammatory cytokine IL-
103. Therefore, we suggest that in relatively normal lung 
tissue, the anti-inflammatory environment is produced 
by the down-regulation of pro-inflammatory cytokines. 
We found a higher number of IL-4 –containing struc-
tures in the bronchial epithelium and alveolar epithe-
lium but a slightly lower number of structures in other 
tissue groups, as well as alveolar macrophages. In lung 
tissue, IL-4 upregulates the adhesion molecules on the 
epithelium while regulating the inflammatory response, 
promotes increased airway responsiveness, and ensures 
and increases goblet cell hyperplasia; moreover, enhanced 
immunoglobulin (Ig) E switching, mast cell involvement, 
and eosinophilia, as well as higher mucus hyperproduc-
tion and overall higher airway tissue responsiveness have 
been described8,17. Although we observed a thickening of 
the basal membranes in some of the patients, generally, 
no allergic changes in the tissue were found, assuming the 
production of IL-4 is occurring for other reasons apart 
from allergic conditions. 
Our study shows a more pronounced number of IL-6–
containing structures in the alveolar epithelium, followed 
by the number of IL-6–positive structures in the bron-
chial cartilage and IL-6–containing alveolar macrophages. 
IL-6 was less found in connective tissue and in bronchial 
glands, where rare structures and almost none were found, 
respectively. IL-6 is a pleiotropic cytokine controlling T 
cell infiltration to the lungs, increasing the mucus secre-
tion, up-regulating the mast cell proliferation, and induc-
ing contractions in lung smooth muscle cells. Importantly, 
IL-6 mediates the pro-inflammatory, pro-angiogenic and 
immunomodulatory role of other cells19. As observed, 
IL-6 is produced early during the infection from unin-
fected cells compared with infected cells, suggesting its 
regulatory role26. As we found, the major sources of IL-6 
are structures more exposed to airborne antigens, and 
the understanding of IL-6 functions may be explained as 
a more intermediate occurrence in subsequent signalling 
with a regulatory role, rather than an initiating factor of 
immune response induction due to antigen stimulation. 
A higher number of IL-7–containing structures were 
found in bronchial cartilage, followed by location in the 
bronchial epithelium and the number of IL-7–positive 
alveolar macrophages. Fewer IL-7–containing structures 
were found in the alveolar epithelium, connective tissue 
and bronchial glands. Although IL-7 is found to be se-
creted by mostly immune cells, as well as supporting cells 
affecting the development, differentiation and functioning 
of lymphocytes21, our results suggest other non-immune 
sources. Surprisingly, bronchial cartilage was the most 
pronounced source for IL-7 affecting the local regulation. 
However, the role of IL-7 in local immunity is still unclear 
because the number of studies describing the role of this 
cytokine in tissues other than lymphoid is limited.
Our study shows that the predominant distribution of 
IL-10 is higher in bronchial cartilage, ranging from few 
to numerous IL-10–containing chondrocytes, followed by 
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the number of IL-10–containing alveolar macrophages 
and the number of structures in the bronchial epithe-
lium. Fewer IL-10–containing structures were found in 
the alveolar epithelium and bronchial glands. Few to a 
moderate number of interleukin-containing alveolar mac-
rophages, ranging from no positive alveolar macrophages 
for any other cytokine to numerous IL-10–containing al-
veolar macrophages were found. However, a lower num-
ber of IL-1–containing alveolar macrophages were found. 
Interestingly, our study results reveal that all structures at 
first exposed to antigens sourcing from inhaled air (bron-
chial epithelium, alveolar epithelium, and alveolar mac-
rophages) contained less IL-1 and more IL-10, affecting 
their own activity in an anti-inflammatory manner. The 
anti-inflammatory response to the initiated inflammation 
shows a signalling background between pro-inflammatory 
and anti-inflammatory cytokines, suggesting that cells ca-
pable of expressing IL-10 have powerful sources of con-
trolling the immune response into the anti-inflammatory 
direction27. 
As we examined relatively normal tissue without any 
clinical and microscopic evidence of acute inflammatory 
condition, our weak findings of IL-1–containing struc-
tures confirms the understanding of relatively normal 
tissue with a preparedness to ignite a full-scale immune 
response towards inflammation if necessary and dedicat-
ed to the status of tissue affected by antigens. Alveolar 
macrophages unique to lung tissue play a pivotal role in 
maintaining local immunity. Moreover, alveolar macro-
phages elicit and further amplify the immune response28,29. 
Importantly, the amount of secreted anti-inflammatory 
cytokine IL-10 decreases, suggesting the inflammatory 
response predominance over the tissue anti-inflammatory 
response, if excited by an antigen. Although epithelial tis-
sue is also a source of cytokines, alveolar macrophages are 
overall more potent producers of inflammatory mediators 
than is the epithelium28. Antigen exposure causes an in-
crease in acute phase inflammatory cytokines IL-1β, IL-6 
produced by alveolar macrophages6,7.
As an example of cells regulating the immune system, 
alveolar macrophages are constantly excited by direct 
exposure to the inhaled antigens through breathing; how-
ever, the following pro-inflammatory signalling is strictly 
controlled and regulated to prevent lung tissue from pos-
sible damage due to the full-scale immune response. Not 
excited by incoming potentially harmful antigens, macro-
phages function in a relatively silent mode; however, at the 
same time, alveolar macrophages are ready to be excited. 
In this state, macrophages suppress the local immunity 
by producing low levels of cytokines and other signalling 
molecules29. Although alveolar macrophages are found 
to initiate and maintain the immune response in the in-
flammatory mode, the contributing factors strongly affect 
the behaviour of alveolar macrophages. The certain estab-
lishment of intercommunication between alveolar mac-
rophages and alveolar epithelial cells directly enhances 
the immunomodulation in an immunosuppressive way30, 
but we found possible evidence of both paracrine and 
autocrine regulation by either neighbouring cells or by 
the cells themselves, respectively. 
Although we did not analyse the cytokine contents in 
the mucus covering the epithelium, we inspected the bron-
chial glands containing all examined cytokines. Except for 
few cases where a moderate number of interleukin-con-
taining glandulocytes were found, we obtained an almost 
negative result, with either no positive cells or mostly rare 
interleukin-containing glandulocytes. Mucus secreted 
by both secretory cells and bronchial glands works as a 
complex defence system containing multiple protective 
molecules; therefore, we hypothesize that the primary 
source of cytokines in mucus are not glandulocytes in 
bronchial glands. Importantly, goblet cells as a one of the 
secretory cell types are resident and specific to the airway 
epithelium, where they actively participate in innate and 
acquired immune responses ongoing throughout the nasal 
cavity, trachea, conducting bronchi and bronchioles8,9. 
Although induced by IL-13, particularly IL-4, IL-6 and 
IL-7 are secreted from goblet cells in significantly greater 
amounts compared with ciliated cells, and these cytokines 
are expected to also be found in the mucus layer. IL-1RA 
and IL-10 were also secreted from goblet cells in greater 
amounts at the apical surface and basolaterally, respec-
tively31. Goblet cells apart from other cell types in tissue 
specimens processed for immunohistochemistry were 
analysed by semi-quantitative grading, where they showed 
mostly low-grade colouring. However, this understanding 
partly fits with our findings in the bronchial epithelium, 
where all were found up to a mostly moderate number, 
but in some cases up to numerous interleukin-containing 
structures.
We found rare to few interleukin-containing structures 
in the connective tissue, with a greater number of IL-
10–containing connective tissue fibroblasts. From many 
pro-inflammatory, modulating and anti-inflammatory cy-
tokines, chemokines and cell adhesion molecules, lung 
fibroblasts are found to produce IL-1, IL-4, and IL-6. 
Airway smooth muscle cells have been described to se-
crete cytokines IL-1, IL-6, and IL-10 (ref.32). Because of 
damage to the cellular structure, epithelial cells release 
IL-1α to trigger sufficient inflammatory responses in 
deeper connective tissue fibroblasts33. Although epithe-
lial tissue as a lining structure is a more potent producer 
of cytokines, and the underlying connective tissue shows 
low, but efficient, amounts of interleukin-containing fi-
broblasts. A more prominent number of IL-10–contain-
ing fibroblasts was found compared with other tissues, 
suggesting the anti-inflammatory environment was also 
deeper in the tissue.
Interestingly, we found a prominent source of IL-7 
and IL-10 in the bronchial cartilage, where moderate to 
numerous hypertrophic chondrocytes, as well as chondro-
blasts positive for IL-7 and IL-10 were found. Although 
as an early damage pathogen recognition site is in epithe-
lial tissue and alveolar macrophages, other non-immune 
structures greatly contribute to the initiation, regulation 
and suppression of the immune response. The epithe-
lium stimulates immune cells and ignites the innate and 
adaptive immunity signaling3; moreover, alveolar macro-
phages easily initiate both local and systemic immune 
responses, as well as recruit other immune mediators, 
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leading to inflammation28,29. However, the influence of 
deeper structures to initiate, regulate and suppress the 
immune responses is poorly evidenced. We suggest the 
influence of deeper tissue structures in the wall on a larger 
histological structure, but they mostly regulate the local 
immune responses by localizing pathological conditions 
(e.g., inflammation, infection, malignancies, etc.) to pre-
vent spreading throughout the tissue. 
We evaluated the relationship between the age of 
an individual and the number of interleukin-containing 
structures in all examined tissue, where no statistically 
significant (P < 0.05) correlations were found. Although 
cellular defects play an important role in the outcomes 
due to the aging, both local and systemic environments 
are reorganized towards the inflammation34. A persistent 
low-grade, chronic, systemic pro-inflammatory state de-
scribed in aging is termed as “inflammaging” or immu-
nosenescence35-37. A significant increase in IL-6 and IL-1β 
due to increasing age was observed. IL-10 was equivalent 
to the measurements in younger study subjects. An overall 
basal increase of pro-inflammatory cytokines is observed 
with aging38. Although we evaluated structures containing 
proinflammatory cytokines, we observed more IL-10–con-
taining structures, suggesting the predominance of anti-
inflammation is explained as controlling conditions to 
suppress and regulate the inflammatory environment in 
relatively healthy lungs regardless of age.
CONCLUSION
The predominance of IL-10–positive structures in all 
examined tissue groups indicates the anti-inflammatory 
response in relatively healthy lung tissue. The weak find-
ings of IL-4–containing structures except in structures 
more exposed to the outer environment may prove the 
deficiency of allergic changes in tissue samples mirror-
ing the ontogenetic aspects. The widespread findings of 
IL-6–positive structures suggest the continuous stimula-
tion of cytokine expression in lung tissue. The relative 
distribution of IL-7 in all tissue groups indicates the local 
regulatory and modulating patterns involving non-immune 
cells and alveolar macrophages. The pronounced distribu-
tion of all the cytokines in bronchial cartilage suggests the 
involvement of a compensatory local immune response 
in supporting tissues.
Author contributions: This work was conducted as a col-
laboration between all the authors (ZV: literature search, 
routine and immunohistochemistry analysis, writing the 
manuscript, statistical analysis; MP: design of the study, 
writing the protocol, patient selection, routine and immu-
nohistochemistry analysis; ZV, MP: data interpretation). 
All authors read and approved the final manuscript. 
Conflict of interest statement: The authors state that there 
are no conflicts of interest regarding the publication of 
this article.
REFERENCES
 1. McAleer JP, Kolls JK. Directing traffic: IL-17 and IL-22 coordinate pul-
monary immune defense. Immunol Rev 2014;260:129-44.
 2. Mizgerd JP. Respiratory Infection and the Impact of Pulmonary 
Immunity on Lung Health and Disease. Am J Respir Crit Care Med 
2012;186:824-9.
 3. Hallstrand TS, Hackett TL, Altemeier WA, Matute-Bello G, Hansbro 
PM, Knight DA. Airway epithelial regulation of pulmonary immune 
homeostasis and inflammation. Clin Immunol 2014;151:1-15.
 4. Lambrecht BN, Hammad H. Allergens and the airway epithelium 
response: Gateway to allergic sensitization. J Allergy Clin Immunol 
2014;134:499-507.
 5. Vareille M, Kieninger E, Edwards MR, Regamey N. The Airway 
Epithelium: Soldier in the Fight against Respiratory Viruses. Clin 
Microbiol Rev 2011;24:210.
 6. Chen K, Kolls JK. T Cell-Mediated Host Immune Defenses in the Lung. 
In: Littman DR, Yokoyama WM, eds. Annu Rev Immunol Vol 31. Palo 
Alto: Annual Reviews; 2013:605-33.
 7. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate 
immune system. Nat Immunol 2015;16:343-53.
 8. Munkholm M, Mortensen J. Mucociliary clearance: pathophysiologi-
cal aspects. Clin Physiol Funct Imaging 2014;34:171-7.
 9. Evans CM, Koo JS. Airway mucus: The good, the bad, the sticky. 
Pharmacol Ther 2009;121:332-48.
10. Fahy JV, Dickey BF. Medical Progress: Airway Mucus Function and 
Dysfunction. N Engl J Med 2010;363:2233-47.
11. Morales-Nebreda L, Misharin AV, Perlman H, Budinger GRS. The het-
erogeneity of lung macrophages in the susceptibility to disease. Eur 
Respir Rev 2015;24:505-9.
12. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker 
CD, See P, Price J, Lucas D, Greter M, Mortha A, Boyer SW, Forsberg 
EC, Tanaka M, van Rooijen N, García-Sastre A, Stanley ER, Ginhoux F, 
Frenette PS, Merad M. T Tissue-resident macrophages self-maintain 
locally throughout adult life with minimal contribution from circulat-
ing monocytes. Immunity 2013;38:792-804.
13. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, 
Jung S, Amit I. Tissue-Resident Macrophage Enhancer Landscapes 
Are Shaped by the Local Microenvironment. Cell 2014;159:1312-26.
14. Garlanda C, Dinarello CA, Mantovani A. The Interleukin-1 Family: 
Back to the Future. Immunity 2013;39:1003-8.
15. Ranasinghe C, Trivedi S, Wijesundara DK, Jackson RJ. IL-4 and IL-
13 receptors: Roles in immunity and powerful vaccine adjuvants. 
Cytokine Growth Factor Rev 2014;25:437-42.
16. Luzina IG, Todd NW, Sundararajan S, Atamas SP. The cytokines of 
pulmonary fibrosis: Much learned, much more to learn. Cytokine 
2015;74:88-100.
17. Lee N, Shin MS, Kang I. T-Cell Biology in Aging, With a Focus on Lung 
Disease. J Gerontol A Biol Sci Med Sci 2012;67:254-63.
18. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and 
anti-inflammatory properties of the cytokine interleukin-6. Biochim 
Biophys Acta 2011;1813:878-88.
19. Xia YC, Redhu NS, Moir LM, Koziol-White C, Ammit AJ, Al-Alwan L, 
Camoretti-Mercado B, Clifford RL. Pro-inflammatory and immuno-
modulatory functions of airway smooth muscle: Emerging concepts. 
Pulm Pharmacol Ther 2013;26:64-74.
20. Kang J, Coles M. IL-7: The global builder of the innate lymphoid net-
work and beyond, one niche at a time. Semin Immunol 2012;24:190-
7.
21. Zaunders JJ, Levy Y, Seddiki N. Exploiting differential expression of 
the IL-7 receptor on memory T cells to modulate immune responses. 
Cytokine Growth Factor Rev 2014;25:391-401.
22. Guesdon JL, Ternynck T, Avrameas S. The Use Of Avidin Biotin 
Interaction In Immuno Enzymatic Techniques. J Histochem 
Cytochem 1979;27:1131-9.
23. Tobin G, Luts A, Sundler F, Ekstrom J. Peptidergic Innervation Of The 
Major Salivary Glands Of The Ferret. Peptides (N.Y.) 1990;11:863-8.
24. Pilmane M, Rumba I, Sundler F, Luts A. Patterns of occurrence and 
distribution of neuroendrocine elements in lungs of humans with 
chronic lung diseases. Proceedings of the Latvian Academy of 
Sciences Section B Natural Exact and Applied Sciences 1998;52:144-
52.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun; 161(2):164-173.
173
25. Mukaka MM. Statistics Corner: A guide to appropriate use 
of Correlation coefficient in medical research. Malawi Med J 
2012;24:69-71.
26. Copenhaver AM, Casson CN, Nguyen HT, Duda MM, Shin S. IL-1R 
signaling enables bystander cells to overcome bacterial blockade 
of host protein synthesis. Proc Natl Acad Sci U S A 2015;112:7557-62.
27. Jin J-O, Han X, Yu Q. Interleukin-6 induces the generation of IL-10-
producing Tr1 cells and suppresses autoimmune tissue inflamma-
tion. J Autoimmun 2013;40:28-44.
28. Hiraiwa K, van Eeden SF. Contribution of lung macrophages to the 
inflammatory responses induced by exposure to air pollutants. 
Mediators Inflamm 2013;2013:619523-619523.
29. Divangahi M, King IL, Pernet E. Alveolar macrophages and type I IFN in 
airway homeostasis and immunity. Trends Immunol 2015;36:307-14.
30. Westphalen K, Gusarova GA, Islam MN, Subramanian M, Cohen 
TS, Prince AS, Bhattacharya J. Sessile alveolar macrophages com-
municate with alveolar epithelium to modulate immunity. Nature 
2014;506(7489):503-6. doi: 10.1038/nature12902
31. Tanabe T, Rubin BK. Airway Goblet Cells Secrete Pro-Inflammatory 
Cytokines, Chemokines, and Growth Factors. Chest 2016;149:714-20.
32. Alkhouri H, Poppinga WJ, Tania NP, Ammit A, Schuliga M. Regulation 
of pulmonary inflammation by mesenchymal cells. Pulm Pharmacol 
Ther 2014;29:156-65.
33. Suwara MI, Green NJ, Borthwick LA, Mann J, Mayer-Barber KD, Barron 
L, Corris PA, Farrow SN, Wynn TA, Fisher AJ, Mann DA IL-1 alpha re-
leased from damaged epithelial cells is sufficient and essential to 
trigger inflammatory responses in human lung fibroblasts. Mucosal 
Immunol 2014;7:684-93.
34. Kirkwood TBL. Understanding the odd science of aging. Cell 
2005;120:437-47.
35. Franceschi C. Inflammaging as a major characteristic of old people: 
Can it be prevented or cured? Nutr Rev 2007;65:S173-S176.
36. Lalley PM. The aging respiratory system-Pulmonary structure, func-
tion and neural control. Respir Physiol Neurobiol 2013;187:199-210.
37. Canan CH, Gokhale NS, Carruthers B, Lafuse WP, Schlesinger LS, 
Torrelles JB, Turner J. Characterization of lung inflammation and its 
impact on macrophage function in aging. J Leukoc Biol 2014;96:473-
480.
38. Moliva JI, Rajaram MVS, Sidiki S, Sasindran SJ, Guirado E, Pan XJ, 
Wang SH, Ross P Jr, Lafuse WP, Schlesinger LS, Turner J, Torrelles JB. 
Molecular composition of the alveolar lining fluid in the aging lung. 
Age (Dordr) 2014;36(3):9633. doi: 10.1007/s11357-014-9633-4
